BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+13.81%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.53B
AUM Growth
+$7.53B
(+8.1%)
Cap. Flow
-$9.29M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
36.11%
Holding
184
New
8
Increased
71
Reduced
51
Closed
13
Top Buys
| 1 |
Incyte
INCY
|
$17.1M |
| 2 |
Intuitive Surgical
ISRG
|
$15.7M |
| 3 |
DexCom
DXCM
|
$14.5M |
| 4 |
Centene
CNC
|
$13.5M |
| 5 |
Abbott
ABT
|
$12.6M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$40.9M |
| 2 |
UnitedHealth
UNH
|
$38.4M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$32.9M |
| 4 |
Elevance Health
ELV
|
$27.2M |
| 5 |
Molina Healthcare
MOH
|
$18M |
Sector Composition
| 1 | Healthcare | 99.55% |
| 2 | Industrials | 0.38% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tandem Diabetes Care
TNDM
$834M
| $80.5M | 1.07% |
1,791,450
+225,435
| +14% | +$10.1M |
|
27
Celldex Therapeutics
CLDX
$1.57B
| $80.2M | 1.06% |
1,800,000
| – | – |
|
28
HCA Healthcare
HCA
$95.4B
| $79.5M | 1.06% |
331,306
+45,517
| +16% | +$10.9M |
|
29
Edwards Lifesciences
EW
$47.7B
| $79.4M | 1.05% |
1,064,131
+38,416
| +4% | +$2.87M |
|
|
30
Elevance Health
ELV
$72.4B
| $76.6M | 1.02% |
149,421
-53,071
| -26% | -$27.2M |
|
31
Arvinas
ARVN
$580M
| $73.6M | 0.98% |
2,150,412
-40,350
| -2% | -$1.38M |
|
32
Outset Medical
OM
$245M
| $73.4M | 0.97% |
189,579
+28,415
| +18% | +$11M |
|
33
Option Care Health
OPCH
$4.7B
| $73.1M | 0.97% |
2,430,422
-198,750
| -8% | -$5.98M |
|
34
Insmed
INSM
$30.3B
| $65.5M | 0.87% |
3,277,207
+62,503
| +2% | +$1.25M |
|
35
Exact Sciences
EXAS
$9.33B
| $65M | 0.86% |
1,312,015
+182,362
| +16% | +$9.03M |
|
36
Charles River Laboratories
CRL
$7.99B
| $63.2M | 0.84% |
289,977
+26,984
| +10% | +$5.88M |
|
37
Relay Therapeutics
RLAY
$709M
| $62.8M | 0.83% |
4,204,820
| – | – |
|
|
38
Molina Healthcare
MOH
$9.6B
| $61.4M | 0.82% |
186,014
-54,576
| -23% | -$18M |
|
39
MacroGenics
MGNX
$121M
| $60.3M | 0.8% |
8,979,913
+1,654,399
| +23% | +$11.1M |
|
40
Apellis Pharmaceuticals
APLS
$3.51B
| $57.1M | 0.76% |
1,104,217
+96,773
| +10% | +$5M |
|
|
41
Centene
CNC
$14.8B
| $56.9M | 0.75% |
693,558
+165,118
| +31% | +$13.5M |
|
42
Humana
HUM
$37.5B
| $56.6M | 0.75% |
110,539
-23,667
| -18% | -$12.1M |
|
43
Evolent Health
EVH
$1.11B
| $55.7M | 0.74% |
1,983,653
+114,598
| +6% | +$3.22M |
|
|
SILK
44
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $53.5M | 0.71% |
1,012,523
-34,833
| -3% | -$1.84M |
|
45
Pacific Biosciences
PACB
$378M
| $53M | 0.7% |
6,478,925
+1,039,374
| +19% | +$8.5M |
|
46
Cigna
CI
$80.2B
| $52.6M | 0.7% |
158,621
-30,080
| -16% | -$9.97M |
|
|
AMED
47
DELISTED
Amedisys
AMED
| $51.3M | 0.68% |
613,512
+14,578
| +2% | +$1.22M |
|
|
SWAV
48
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $50.9M | 0.68% |
247,616
-28,516
| -10% | -$5.86M |
|
49
Globus Medical
GMED
$7.94B
| $50.5M | 0.67% |
680,180
+33,017
| +5% | +$2.45M |
|
50
Penumbra
PEN
$10.5B
| $50.2M | 0.67% |
225,817
+36,043
| +19% | +$8.02M |
|